Patent · US Expired

Culturing human pancreatic endocrine cells in medium containing extracellular matrix from human bladder carcinoma cells

US5874306A · kind A · utility

20Cited by
6References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 1996
Grant dateFeb 23, 1999
Priority date
Expiry dateDec 12, 2016

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2502/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Human pancreatic endocrine cells are proliferated without loss of hormone function in a culture medium containing extracellular matrix from bladder carcinoma cell lines in the substantial absence of hepatocyte growth factor/scatter factor. Proliferation is preferably carried out in the substantial absence of any peptide growth factors and nicotinamide. The cells may be proliferated in a monolayer on a solid substrate. Islets and islet-like cell clusters are proliferated without loss of insulin-secreting function by incubation in a medium containing extracellular matrix from a human bladder carcinoma cell line, preferably cell line ATCC HTB-9.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.